Nirsevimab Effectiveness Against RSV‐Related Hospitalisations in Children Under 24 Months: A Test‐Negative Case–Control Study in Portugal, 2024–2025Vânia Gaio, Rita Canas‐Marques, Raquel Marques et al.|Influenza and Other Respiratory Viruses|2025Cited by 2
Author response for "Nirsevimab effectiveness against RSV-related hospitalisations in children under 24 months: a test-negative case–control study in Portugal, 2024–2025"Vânia Gaio, VigiRSV group, Camila Henriques et al.|Unknown|2025Cited by 0